Trademark: 90715573
Status Date
Tuesday, February 20, 2024
Filing Date
Monday, May 17, 2021
Published for Opposition
Tuesday, December 28, 2021
5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system
The English translation of the word "ACUMA" in the mark is "now".
Feb 21, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 20, 2024
Sou Extension 4 Granted
Feb 20, 2024
Sou Extension 4 Filed
Feb 20, 2024
Sou Teas Extension Received
Aug 18, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 16, 2023
Sou Extension 3 Granted
Aug 16, 2023
Sou Extension 3 Filed
Aug 16, 2023
Sou Teas Extension Received
Feb 16, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 14, 2023
Sou Extension 2 Granted
Feb 14, 2023
Sou Extension 2 Filed
Feb 14, 2023
Sou Teas Extension Received
Feb 2, 2023
Teas Change Of Correspondence Received
Feb 2, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 2, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 2, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 26, 2022
Sou Extension 1 Granted
Jul 26, 2022
Sou Extension 1 Filed
Jul 26, 2022
Sou Teas Extension Received
Jul 7, 2022
Teas Change Of Correspondence Received
Jul 7, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 7, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 28, 2021
Published For Opposition
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Nov 19, 2021
Approved For Pub - Principal Register
Nov 19, 2021
Examiner's Amendment Entered
Nov 19, 2021
Notification Of Examiners Amendment E-Mailed
Nov 19, 2021
Examiners Amendment E-Mailed
Nov 19, 2021
Examiners Amendment -Written
Nov 17, 2021
Notification Of Non-Final Action E-Mailed
Nov 17, 2021
Non-Final Action E-Mailed
Nov 17, 2021
Non-Final Action Written
Nov 12, 2021
Assigned To Examiner
Aug 14, 2021
New Application Office Supplied Data Entered
May 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
